167
Participants
Start Date
May 31, 2010
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
Eltrombopag olamine
Thrombopoietin receptor agonist
GSK Investigational Site, Debrecen
GSK Investigational Site, Szeged
GSK Investigational Site, Győr
GSK Investigational Site, New York
GSK Investigational Site, Berlin
GSK Investigational Site, Caen
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Pessac
GSK Investigational Site, Padua
GSK Investigational Site, Vicenza
GSK Investigational Site, Bologna
GSK Investigational Site, Düsseldorf
GSK Investigational Site, Düsseldorf
GSK Investigational Site, Essen
GSK Investigational Site, Lahore
GSK Investigational Site, Karachi
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Créteil
GSK Investigational Site, Moscow
GSK Investigational Site, Ludhiana
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Surat
GSK Investigational Site, Pune
GSK Investigational Site, Novosibirsk
GSK Investigational Site, Vellore
GSK Investigational Site, Hradec Králové
GSK Investigational Site, Shatin, New Territories
GSK Investigational Site, Olomouc
GSK Investigational Site, Prague
GSK Investigational Site, Seongnam-si Gyeonggi-do
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
Lead Sponsor
GlaxoSmithKline
INDUSTRY